Related Experiment Videos
Mivacurium in short to intermediate surgical procedures
1Department of Anaesthetics, St Mary's Hospital Medical School, Imperial College, Paddington, London, UK.
Acta Anaesthesiologica Scandinavica. Supplementum
|January 1, 1995
Summary
Mivacurium, a benzylisoquinoline muscle relaxant, is suitable for short surgeries. It shows good tolerability and cardiovascular stability in young and elderly patients with normal cholinesterase function.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Muscle relaxants are crucial in surgical procedures.
- Benzylisoquinoline compounds offer potential advantages in anesthesia.
- Mivacurium represents a novel option for neuromuscular blockade.
Purpose of the Study:
- To evaluate mivacurium as an ideal muscle relaxant for short to intermediate surgeries.
- To assess the onset and offset times of mivacurium.
- To determine the cardiovascular stability of mivacurium in different patient populations.
Main Methods:
- Two clinical studies were conducted.
- Onset and offset times of mivacurium were recorded.
- Cardiovascular parameters were monitored in young and elderly patients.
Main Results:
- Mivacurium demonstrated appropriate onset and offset times for short procedures.
- Cardiovascular stability was maintained in both young and elderly participants.
- A slight prolongation of action was observed in elderly patients.
Conclusions:
- Mivacurium is a well-tolerated neuromuscular blocking agent.
- It is appropriate for short to intermediate surgical procedures in patients with normal plasma cholinesterase.
- Elderly patients may experience a slightly longer duration of action.